University of Alabama Medical center

Birmingham, Alabama 35401

3 studies enrolling now · 16 studies all time

What they study most

Acute Pancreatitis, Acute Respiratory Distress Syndrome, Aneurysm, Atrial Fibrillation, B-Cell Lymphoma, Bleeding, Cesarean Section, Congenital Heart Disease, SRV Dependent, Critical Illness, Crohn's Disease, Hemolytic Anemia, Iron Deficiency Anemia

Studies at this site

• Treatment of Antibody-Mediated Rejection (ABMR) With CarBel — Recruiting now
• Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy — Recruiting now
• HEAL-LAA Clinical Trial — Completed
• Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis — Enrolling by invitation
• Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD — Running, not enrolling
• A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL — Completed
• Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies — Stopped early
• Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery — Completed
• Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects — Completed
• Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial — Stopped early
• Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial — Stopped early
• Thoracic Endoprosthesis for Treatment of Aneurysm of the Descending Thoracic Aortic — Completed
• Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma — Completed
• GORE PROPATEN Vascular Graft vs. Disadvantaged Autologous Vein Graft — Stopped early
• Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients — Completed
• A Study of Abatacept in Patients With Active Crohn's Disease — Stopped early